1st Quarter - Report

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$2,870,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 19, 2013 $2,870,000 Replaced
1st Quarter - Report May 1, 2013 $2,890,000 Replaced
1st Quarter - Amendment May 1, 2013 $2,890,000 Replaced
1st Quarter - Amendment Mar 14, 2014 $2,920,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3817 (113th)

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations India Trade issues

LobbyistCovered position, as disclosed
ANGELA WALKER RIEMER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Alcohol and Drug Abuse ALC

Opioid Abuse Prescription Drug Abuse

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —

Contacted: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); State, Dept of (DOS); SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Taxation/Internal Revenue Code TAX

Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
CAROLINE MOODY SCHELLHAS —

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); State, Dept of (DOS); SENATE

Bills named: H.R. 2735 (113th), H.R. 8 (113th)

Copyright/Patent/Trademark CPT

Patent Settlements

LobbyistCovered position, as disclosed
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Executive Office of the President (EOP); SENATE; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Certified Importer Program Supply Chain Issues

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.